563 related articles for article (PubMed ID: 33754931)
1. COVID-19 infection and rheumatoid arthritis: mutual outburst cytokines and remedies.
Elemam NM; Maghazachi AA; Hannawi S
Curr Med Res Opin; 2021 Jun; 37(6):929-938. PubMed ID: 33754931
[TBL] [Abstract][Full Text] [Related]
2. A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab.
Cai S; Sun W; Li M; Dong L
Clin Rheumatol; 2020 Sep; 39(9):2797-2802. PubMed ID: 32562070
[TBL] [Abstract][Full Text] [Related]
3. Use of conventional synthetic and biologic disease-modifying anti-rheumatic drugs in patients with rheumatic diseases contracting COVID-19: a single-center experience.
Migkos MP; Kaltsonoudis E; Pelechas E; Drossou V; Karagianni PG; Kavvadias A; Voulgari PV; Drosos AA
Rheumatol Int; 2021 May; 41(5):903-909. PubMed ID: 33655421
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 infection and rheumatoid arthritis: Faraway, so close!
Favalli EG; Ingegnoli F; De Lucia O; Cincinelli G; Cimaz R; Caporali R
Autoimmun Rev; 2020 May; 19(5):102523. PubMed ID: 32205186
[TBL] [Abstract][Full Text] [Related]
5. Immunopathogenesis and treatment of cytokine storm in COVID-19.
Kim JS; Lee JY; Yang JW; Lee KH; Effenberger M; Szpirt W; Kronbichler A; Shin JI
Theranostics; 2021; 11(1):316-329. PubMed ID: 33391477
[TBL] [Abstract][Full Text] [Related]
6. Clinical management of patients with rheumatoid arthritis during the COVID-19 pandemic.
Favalli EG; Maioli G; Biggioggero M; Caporali R
Expert Rev Clin Immunol; 2021 Jun; 17(6):561-571. PubMed ID: 33787418
[No Abstract] [Full Text] [Related]
7. COVID-19 and Rheumatoid Arthritis Crosstalk: Emerging Association, Therapeutic Options and Challenges.
Dewanjee S; Kandimalla R; Kalra RS; Valupadas C; Vallamkondu J; Kolli V; Dey Ray S; Reddy AP; Reddy PH
Cells; 2021 Nov; 10(12):. PubMed ID: 34943795
[TBL] [Abstract][Full Text] [Related]
8. Baricitinib, a drug with potential effect to prevent SARS-COV-2 from entering target cells and control cytokine storm induced by COVID-19.
Zhang X; Zhang Y; Qiao W; Zhang J; Qi Z
Int Immunopharmacol; 2020 Sep; 86():106749. PubMed ID: 32645632
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Role of Tocilizumab in SARS-CoV-2-Induced Cytokine Storm: Rationale and Current Evidence.
Pelaia C; Calabrese C; Garofalo E; Bruni A; Vatrella A; Pelaia G
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802761
[TBL] [Abstract][Full Text] [Related]
10. Small Molecule Inhibitors in the Treatment of Rheumatoid Arthritis and Beyond: Latest Updates and Potential Strategy for Fighting COVID-19.
Massalska M; Maslinski W; Ciechomska M
Cells; 2020 Aug; 9(8):. PubMed ID: 32796683
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 and rheumatoid arthritis.
D'Silva KM; Wallace ZS
Curr Opin Rheumatol; 2021 May; 33(3):255-261. PubMed ID: 33625043
[TBL] [Abstract][Full Text] [Related]
12. Population-level interest in anti-rheumatic drugs in the COVID-19 era: insights from Google Trends.
Kardeş S; Kuzu AS; Pakhchanian H; Raiker R; Karagülle M
Clin Rheumatol; 2021 May; 40(5):2047-2055. PubMed ID: 33130946
[TBL] [Abstract][Full Text] [Related]
13. POST-COVID-19 INFLAMMATORY RHEUMATOID ARTHRITIS REMISSION.
Hayashi T; Konishi I
Georgian Med News; 2024 Mar; (348):57-59. PubMed ID: 38807392
[TBL] [Abstract][Full Text] [Related]
14. Can emapalumab be life saving for refractory, recurrent, and progressive cytokine storm caused by COVID-19, which is resistant to anakinra, tocilizumab, and Janus kinase inhibitors.
Cure E; Kucuk A; Cure MC
Indian J Pharmacol; 2021; 53(3):226-228. PubMed ID: 34169908
[TBL] [Abstract][Full Text] [Related]
15. The Perfect Storm: A Rheumatologist's Point of View on COVID-19 Infection.
Kobak S
Curr Rheumatol Rev; 2021; 17(2):141-152. PubMed ID: 33121412
[TBL] [Abstract][Full Text] [Related]
16. Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry.
Gianfrancesco M; Hyrich KL; Al-Adely S; Carmona L; Danila MI; Gossec L; Izadi Z; Jacobsohn L; Katz P; Lawson-Tovey S; Mateus EF; Rush S; Schmajuk G; Simard J; Strangfeld A; Trupin L; Wysham KD; Bhana S; Costello W; Grainger R; Hausmann JS; Liew JW; Sirotich E; Sufka P; Wallace ZS; Yazdany J; Machado PM; Robinson PC;
Ann Rheum Dis; 2020 Jul; 79(7):859-866. PubMed ID: 32471903
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 revisiting inflammatory pathways of arthritis.
Schett G; Manger B; Simon D; Caporali R
Nat Rev Rheumatol; 2020 Aug; 16(8):465-470. PubMed ID: 32561873
[TBL] [Abstract][Full Text] [Related]
18. Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry.
Sparks JA; Wallace ZS; Seet AM; Gianfrancesco MA; Izadi Z; Hyrich KL; Strangfeld A; Gossec L; Carmona L; Mateus EF; Lawson-Tovey S; Trupin L; Rush S; Katz P; Schmajuk G; Jacobsohn L; Wise L; Gilbert EL; Duarte-García A; Valenzuela-Almada MO; Pons-Estel GJ; Isnardi CA; Berbotto GA; Hsu TY; D'Silva KM; Patel NJ; Kearsley-Fleet L; Schäfer M; Ribeiro SLE; Al Emadi S; Tidblad L; Scirè CA; Raffeiner B; Thomas T; Flipo RM; Avouac J; Seror R; Bernardes M; Cunha MM; Hasseli R; Schulze-Koops H; Müller-Ladner U; Specker C; Souza VA; Mota LMHD; Gomides APM; Dieudé P; Nikiphorou E; Kronzer VL; Singh N; Ugarte-Gil MF; Wallace B; Akpabio A; Thomas R; Bhana S; Costello W; Grainger R; Hausmann JS; Liew JW; Sirotich E; Sufka P; Robinson PC; Machado PM; Yazdany J;
Ann Rheum Dis; 2021 Sep; 80(9):1137-1146. PubMed ID: 34049860
[TBL] [Abstract][Full Text] [Related]
19. Biological agents for rheumatic diseases in the outbreak of COVID-19: friend or foe?
Santos CS; Férnandez XC; Moriano Morales C; Álvarez ED; Álvarez Castro C; López Robles A; Pérez Sandoval T
RMD Open; 2021 Jan; 7(1):. PubMed ID: 33455920
[TBL] [Abstract][Full Text] [Related]
20. Chronic conventional disease-modifying anti-rheumatic drugs masking severe SARS-CoV-2 manifestations in an elderly rheumatic patient.
Sagnelli C; Gentile V; Tirri R; Macera M; Cappabianca S; Ciccia F; Coppola N;
J Infect; 2020 Dec; 81(6):979-997. PubMed ID: 32474034
[No Abstract] [Full Text] [Related]
[Next] [New Search]
